期刊文献+

PPARγ激动剂对RSV感染的A549细胞MCP-1、MIP-1α、IL-8表达的作用及机制 被引量:3

Effect and Mechanism of PPARγ Agonists on the Expression of MCP-1,MIP-1α and IL-8 in A549 Cells Infected with Respiratory Syncytial Virus
下载PDF
导出
摘要 目的研究A549细胞呼吸道合胞病毒(RSV)感染不同时间后单核细胞趋化蛋白-1(MCP-1)、巨噬细胞炎性蛋白-1α(MIP-1α)、白介素-8(IL-8)在mRNA和蛋白水平的变化,进一步观察15-脱氧前列腺素J2(15d-PGJ2)和罗格列酮干预后MCP-1、MIP-1α、IL-8 mRNA表达和蛋白水平的变化,探讨PPARγ激动剂对RSV感染趋化因子表达的影响及机制。方法建立RSV感染的细胞模型,将传代培养的细胞随机分成6组:A组(15d-PGJ2+RSV组)、B组(罗格列酮+RSV组)、C组(RSV组)、D组(PDTC+RSV组)、E组(PPARγ拮抗剂GW9662+罗格列酮+RSV组)、F组(细胞对照组),各组分别在培养12、24、48h收获细胞及上清液待测。应用ELISA检测MCP-1、MIP-1α、IL-8蛋白水平,实时定量RT-PCR检测MCP-1、MIP-1α、IL-8 mRNA表达。结果 C组与F组相比,MCP-1、MIP-1α、IL-8 mRNA及蛋白的表达均在12h开始升高,其中mRNA表达在24h达高峰,48h有所下降,与12h比较差异无统计学意义(P均>0.05);而蛋白表达在48h达高峰,与12h比较差异有统计学意义(P均<0.05);D组各时间点3种趋化因子蛋白和mRNA表达均明显低于C组(P均<0.05),但仍高于F组(P均<0.05)。A组、B组与C组相比,各时间点MCP-1、MIP-1α、IL-8蛋白及mRNA表达均明显降低(P均<0.01);E组与C组3种趋化因子蛋白及mRNA表达的差异无统计学意义,但仍高于F组(P均<0.05)。结论 RSV感染可导致MCP-1、MIP-1α、IL-8 mRNA及蛋白表达升高;15d-PGJ2、罗格列酮均可抑制上述作用,其作用可被GW9662所阻断;PPARγ激动剂的作用机制与抑制NF-κB通路激活有关。 Objective To investigate the expression of monocyte chemotactic protein 1 ( MCP - 1 ) , macrophage inflammatory protein -let( MIP- let) and interleukin -8 (IL- 8) both at mRNA and protein levels in A549 cells infected with respiratory syneytial virus (RSV) at different point. Furthermore, to evaluate the changed expression of those chemokines when pretreated with 15 -deoxy- del- tal2, 14 prostaglandin J2 ( 15d - PGJ2 ) or rosiglitazone, and to figure out the mechanism of PPARy agonists. Methods RSV inoculation after A549 cells subcultured,then A549 cells were randomly divided into 6 groups : group A ( 15d - PGJ2 + RSV group) , group B ( rosigli- tazone + RSV group) , group C ( RSV group) , group D ( PDTC + RSV group), group E ( GW9662 + rosiglitazone + RSV group), group F (cell control group). Cells and supernatant were harvested after the cultivation at 12h, 24h and 48h, respectively. ELISA was used to de- tect the protein levels of MCP - 1, MIP - lct and IL - 8 and quantitative real - time PCR was used to test mRNA levels. Results Com- pared with group F, the expression of MCP - 1, MIP - lα and IL -8 both at mRNA and protein levels in group C increased at the begin- ning of 12h, mRNA expression reached the peak at 24h, decreased at 48h and had no significant difference with those at 12h. While, the protein levels reached a peak at 48h and the difference was statistically significant compared with those at 12h (P all 〈 0.05). At each time points, MCP - 1, MIP - let, IL -8 mRNA and protein levels in group D were lower than those in group C, but were still higher than those in group F (P all 〈 O. 05). Compared with group C, MCP - 1, MIP - 1 α, IL - 8 mRNA and protein expression were remarkably decreased in group A and group B (P all 〈0.05). Furthermore, MCP - 1, MIP - lot, IL - 8 mRNA and protein levels, which were higher than group F, indicated no significant difference in group E and group C. Conclusion RSV infections result in the increased ex-pression of MCP- 1, MIP- lα, IL- 8 both at mRNA and protein levels. 15d -PGJ2 and rosiglitazone inhibit this upregu|atory effect. The effects of PPAR - y agonists can be reversed by GW9662. The mechanism is associated with the inhibition of NF - KB pathway activa- tion.
出处 《医学研究杂志》 2015年第2期67-71,共5页 Journal of Medical Research
基金 浙江省自然科学基金资助项目(Y2090932) 温州市科技计划对外合作交流基金资助项目(H20080054)
关键词 PPARΓ激动剂 呼吸道合胞病毒 MCP-1 MIP-1Α IL-8 PPARy agonists Respiratory syncytial virus MCP - 1 MIP -lα IL - 8
  • 相关文献

参考文献17

  • 1Stockman LJ, Curns AT, Anderson LJ, et al. Respiratory syncytial virus - associated hospitalizations among infants agd young children in the United States, 1997 -2006 [ J]. Pediatr Infect Dis J,2012, 31 (1):5-9.
  • 2Perez- Yarza EG, Moreno A, Lazaro P, et al. The association be- tween respiratory virus infection and the development of childhood asthma: a systematic review of the literature[ J]. Pediatr Infect Dis J, 2007,26(8) : 733 -739.
  • 3Hansbro NG, Horvat JC, Wark PA, et al. Understanding the mecha- nisms of viral induced asthma: new therapeutic directions[ J]. Phar- macol Ther, 2008,117(3) : 313 -353.
  • 4Seki E, Yoshizumi M, Tanaka R, et al. Cytokine profiles, signalling pathways and effects of fluticasone propionate in respiratory syncytial virus- infected human foetal lung fibroblasts [ J]. Cell Biol Int, 2013,37(4) : 326 -339.
  • 5Tian B, Zhang Y, Luxon BA, et al. Identification of NF - kappaB -dependent gene networks in respiratory syncytial virus - infected cells [J]. JVirol,2002,76(13): 6800 -6814.
  • 6Zeng R, Li C, Li N, et al. The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma [J]. Cytokine,2011,53(1): 1-7.
  • 7刘琳,董琳,徐月波,陈兆兴,樊节敏,陈小芳.RSV 感染诱导的 RANTES、FKN、IP-10表达及 PPARγ激动剂抑制作用的体外研究[J].中华微生物学和免疫学杂志,2013,33(9):659-665. 被引量:4
  • 8万春杰,董琳,林洁,陈小芳.PPARγ激动剂抗呼吸道合胞病毒感染作用的体外研究[J].中华实验和临床病毒学杂志,2011,25(6):480-482. 被引量:5
  • 9Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity [ J ]. Nat Rev Immunol,2002,2 (10) : 748 - 759.
  • 10Oshansky CM, Barber JP, Crabtree J, et al. Respiratory syncytial vi- rus F and G proteins induce interleukin lalpha, CC, and CXC chemo- kine responses by normal human bronchoepithelial ceils [ J ]. J Infect Dis,2010,201 (8) : 1201 - 1207.

二级参考文献38

  • 1Perez-Yarza EG, Moreno A, Lazaro P, et al. The association between respiratory syncytial virus infection and the development of childhood asthma : a systematic review of the literature. Pediatr Infect Dis J,2007,26:733-739.
  • 2Lusebrink J,Schildgen V, Schildgen O. Novel therapies for an old virus:treatment of RSV infections in the 21st Century. Expert Rev Anti Infect Ther,2009,7 : 1125-1129.
  • 3Potula R, Ramirez SH, Knipe B, et al. Peroxisome proliferator- activated receptor-gamma activation suppresses HIV-I replication in an animal model of encephalitis. AIDS,2008, Aug 20,22 : 1539-1549.
  • 4Arnold R, Ksnig W. Peroxisome proliferator-activated receptor agonists inhibit the replication of respiratory syncytial virus (RSV) in human lung epithelial ceils. Virology,2006,350 : 335-346.
  • 5Lanari M,Silvestri M, Rossi GA. Respiratory syncytial virus risk factors in late preterm infants. J Matern Fetal Neonatal Med, 2009,22 : 102-107.
  • 6Arnold R, Ktinig W. Peroxisome-proliferator-activated receptor-T agonists inhibit the release of proinflammatory cytokines from RSV -infected epithelial cells. Virology, 2006,346:427 -439.
  • 7董琳,陈小芳,周晓聪,林剑,李锦燕,张伟.RSV毛细支气管炎RANTES MIP-1αIL-8水平变化及相关性研究[J].浙江临床医学,2007,9(10):1307-1308. 被引量:8
  • 8Cramer H. Antisense approaches for inhibiting respiratory syncytial virus. Expert Opin Bioi Ther, 2005, 5 ( 2) : 207 -220.
  • 9Perez- Y arza EG, Moreno A, 16zaro P, et al. The association be?tween respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr In?fect Dis 1,2007,26(8): 733-739.
  • 10Chavasse ar, Bastian-Lee Y, Richter H, et al. Persistent wheez?ing in infants with an atopic tendency responds to inhaled flutica?sone. Arch Dis Child, 2001,85(2): 143-148.

共引文献7

同被引文献20

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部